Allenburys Pharma Limited, a active public limited company, was established on 15 October 2020 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U93020WB2020PLC240519. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.05 Cr.
Employing 2 professional, Its leadership includes Anand Kumar Parmanandka (Director), Rubi Mukhopadhyay (Director), Biswajit Pan (Director). It holds ₹10.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor Block B 79 80 Mehta Building 55 B.R.B Basu Road Kolkata 700001, Kolkata, West Bengal, 700001.
U93020WB2020PLC240519
240519
15 October 2020
₹3.00 Cr
₹1.05 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Allenburys Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Kumar Parmanandka | Director | 15 Oct 2020 | Current |
| Rubi Mukhopadhyay | Director | 15 Oct 2020 | Current |
| Biswajit Pan | Director | 15 Oct 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Allenburys Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.15% decrease. The company also saw a substantial fall in profitability, with a 75.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 97.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Allenburys Pharma had a public holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹100,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2023 | Indian Bank | ₹10.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Allenburys Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Allenburys Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allenburys Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Allenburys Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Allenburys Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
A charge with Indian Bank amounted to Rs. 10.00 Cr with Charge ID 100833808 was registered on 22 Dec 2023. was recorded as a recent event.
Progress on Anand Kumar Parmanandka was appointed as a Director was appointed as a Director on 15 Oct 2020 & has been associated with this company since 5 years 1 month . was documented.
Rubi Mukhopadhyay was appointed as a Director was appointed as a Director on 15 Oct 2020 & has been associated with this company since 5 years 1 month . was recorded as a recent event.
The activity Biswajit Pan was appointed as a Director was appointed as a Director on 15 Oct 2020 & has been associated with this company since 5 years 1 month . was completed.
The CIN of Allenburys Pharma Limited is U93020WB2020PLC240519.
Allenburys Pharma Limited is headquartered at 3Rd Floor Block B 79 80 Mehta Building 55 B.R.B Basu Road Kolkata 700001, Kolkata, West Bengal, 700001.
Allenburys Pharma Limited was incorporated on 15 October 2020.
The current directors of Allenburys Pharma Limited are
The primary industry of Allenburys Pharma Limited is Manufacturing.
Allenburys Pharma Limited is unlisted.
The authorized capital of Allenburys Pharma Limited is ₹3.00 Cr, and the paid-up capital is ₹1.05 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX